pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT07136688: Tibial Nerve Stimulation for Pediatric Spina Bifida Neurogenic Bladder

Sponsor: The University of Texas Health Science Center, Houston. Phase: NA. Conditions: Neurogenic Bladder Due to Spina Bifida

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07566442: Frenkel Exercises on Balance and Quality of Life Post Burns

Sponsor: Cairo University. Phase: NA. Conditions: Burns, Lower Limb Burn Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT06597942: Deep Repetitive Transcranial Magnetic Stimulation (rTMS) of the Precuneus for Alzheimer Disease (AD)

Sponsor: University of California, Los Angeles. Phase: PHASE1. Conditions: Alzheimer&Amp;Amp;#39;s Disease, Alzheimer Disease, Dementia Alzheimer Type, Mild Alzheimer&Amp;Amp;#39;s Disease, Moderate Alzheimer&Amp;Amp;#39;s Disease, Alzheimer&Amp;#39;s Disease (AD), Alzheimer&Amp;#39;s Dementia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07561242: Clinical Observational Study on Changes in Skin Physiological Parameters Following Ablative and Non-Ablative Fractional Laser Treatment at Different Doses

Sponsor: ChinaNorm. Phase: . Conditions: Skin Barrier Function, Wound Healing

full page →ctgov ↗
›RECRUITINGphase readoutNCT06124586: Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)

Sponsor: Heinrich-Heine University, Duesseldorf. Phase: NA. Conditions: Diabetic Foot, Diabetes Mellitus, Peripheral Arterial Disease, Diabetic Neuropathies, Diabetic Retinopathy, Anemia, Ulcer Foot, Ulcer Ischemic, Diabetic Polyneuropathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05297786: Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

Sponsor: Vanderbilt University Medical Center. Phase: PHASE2. Conditions: Hemodialysis Complication, Hypotension of Hemodialysis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07340073: Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Parkinson's Disease (PD), Deep Brain Stimulation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06396741: Changes in the Quadriceps Muscle After Dry Needling Treatment

Sponsor: Prof. Dr. Daniel Pecos Martín. Phase: NA. Conditions: Muscle Tightness, Muscle Strain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07220954: A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07479654: AI-Enabled Frailty Risk Prediction in Adult Congenital Heart Disease

Sponsor: Mackay Memorial Hospital. Phase: NA. Conditions: Adult Congenital Heart Disease, Symptom Clusters, Frailty, Risk Prediction Model, Artificial Intelligence-Based Voice Emotion Detection

full page →ctgov ↗
›RECRUITINGphase readoutNCT06866405: A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose

Sponsor: Pfizer. Phase: PHASE3. Conditions: RSV Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT06730594: A Study to Assess the Effect of the Bio-K+ Probiotic Capsules (VL-BK-02) in Adults With Functional Constipation

Sponsor: Vedic Lifesciences Pvt. Ltd.. Phase: NA. Conditions: Functional Constipation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07371741: PICS Clinic Attendance and Recovery Engagement (PICS-CARE)

Sponsor: Charite University, Berlin, Germany. Phase: . Conditions: Post-intensive Care Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05822466: Virtual Tai ji Quan Exercise to Prevent Falls in Older Adults

Sponsor: Oregon Research Institute. Phase: NA. Conditions: Accidental Fall

full page →ctgov ↗
›COMPLETEDphase readoutNCT06160466: Assessing the Additional Neoplasia Yield of Computer-aided Colonoscopy in Follow-up Patients in a Screening Setting

Sponsor: Fondazione Poliambulanza Istituto Ospedaliero. Phase: NA. Conditions: Colonic Adenoma, Adenoma, Polyp of Colon

full page →ctgov ↗
›RECRUITINGphase readoutNCT06700356: Thalamus Seizure Detection With a Deep Brain Stimulator System

Sponsor: Mayo Clinic. Phase: NA. Conditions: Epilepsy; Seizure

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07441356: Female Trauma Cases

Sponsor: Assiut University. Phase: . Conditions: Violence Against Women (VAW)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460856: Effects of Cranberry on Gut and Metabolic Health

Sponsor: Laval University. Phase: NA. Conditions: Overweight/Obesity, Metabolic Syndrome, Insulin Resistance, Microbiota

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07464756: SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: PHASE2. Conditions: Gastric Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06576622: PERIodontal Disease, Microbiota and Miscarriage

Sponsor: University Hospital, Toulouse. Phase: . Conditions: Miscarriage, Parodontitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06438562: Evaluation of Vitamin A Absorption From Fortified Bouillon

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Healthy Volunteers, Vitamin A

full page →ctgov ↗
›RECRUITINGphase readoutNCT07251803: GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound

Sponsor: Medical University of South Carolina. Phase: . Conditions: Gastric Retention

full page →ctgov ↗
›COMPLETEDphase readoutNCT07416903: NT-Based Group Psychoeducation for Parents of Autistic Preschoolers in Türkiye

Sponsor: Kocaeli University. Phase: NA. Conditions: Autism Spectrum Disorder, Parenting Self-efficacy

full page →ctgov ↗
›RECRUITINGphase readoutNCT05005403: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

Sponsor: AbbVie. Phase: PHASE1. Conditions: Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Micro Satellite Stable Colorectal Cancer, Gastric/Esophageal Cancer, High-Grade Serous Ovarian Cancer, Pancreatic Cancer, Triple Negative Breast Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03872427: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor, Unresectable Malignant Solid Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07367061: Clinical Investigation to Assess Safety and Efficacy of INNEA AQUA in Adult Women With Vulvo-Vaginal Atrophy (VVA)

Sponsor: Innate srl. Phase: NA. Conditions: Vulvo Vaginal Atrophy

full page →ctgov ↗
›TERMINATEDphase readoutNCT05042661: Acupuncture-like Transcutaneous Electrical Nerve Stimulation on Bowel Symptom and Quality of Life in Patients With Irritable Bowel Syndrome

Sponsor: National Taipei University of Nursing and Health Sciences. Phase: NA. Conditions: Acupuncture-like Transcutaneous Electrical Nerve Stimulation, Irritable Bowel Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT05665361: Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Clear Cell Renal Carcinoma (Ccrcc), Papillary Renal Cell Carcinoma (Prcc)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07559786: A Multicenter, Randomized, Cohort, Prospective Clinical Study of Adebrelimab Consolidation Therapy for Limited-Stage Small-Cell Lung Cancer (LS-SCLC) Without Progression After Concurrent Chemoradiotherapy

Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: SCLC, Limited Stage

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03849586: Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction

Sponsor: European Association of Urology Research Foundation. Phase: . Conditions: Erectile Dysfunction

full page →ctgov ↗
›TERMINATEDphase readoutNCT05691270: Contraception Navigator Program

Sponsor: Indiana University. Phase: NA. Conditions: Contraception, Contraceptive Usage, Health Care Utilization

full page →ctgov ↗
›RECRUITINGphase readoutNCT07058883: Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

Sponsor: Nordberg Medical AB. Phase: NA. Conditions: Acne Scars

full page →ctgov ↗
›RECRUITINGphase readoutNCT05336383: Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Multiple Myeloma, Plasma Cell Neoplasm, Malignant Plasma Cell Neoplasm

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07258641: Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

Sponsor: University Medical Center Groningen. Phase: PHASE1. Conditions: Ulcerative Colitis (UC), Crohn Disease (CD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05731141: A Prospective Natural History Study of Lymphatic Anomalies

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). Phase: . Conditions: Lymphatic Diseases, Lymphatic Abnormalities

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07454954: The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After Stroke

Sponsor: The First Affiliated Hospital of Zhengzhou University. Phase: NA. Conditions: Stroke, Hemiplegia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07066254: The Mepilex Cesarean Delivery Trial

Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Surgical Site Infection Following Cesarean Delivery

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07348354: Standardization and Application of Pure Platelet-Rich Plasma in Improving Sperm Function

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Infertility

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05462405: Evaluation of Sympathetic Activity Effects by the BackBeat Medical Cardiac Neuromodulation Therapy (CNT).

Sponsor: BackBeat Medical Inc. Phase: NA. Conditions: Hypertension

full page →ctgov ↗
›COMPLETEDphase readoutNCT05790694: A Trial of HBM9378 in Healthy Chinese Subjects

Sponsor: Harbour BioMed (Guangzhou) Co. Ltd.. Phase: PHASE1. Conditions: Asthma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05554094: Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Sponsor: Ohio State University. Phase: PHASE2. Conditions: PTSD, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, Trauma and Stressor Related Disorders, Mental Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT03386266: Biomarkers and Validation of Selected Outcome Measures (CMTBiomarker)

Sponsor: University Medical Center Goettingen. Phase: . Conditions: Charcot-Marie-Tooth Disease, Type IA

full page →ctgov ↗
›RECRUITINGphase readoutNCT06623422: A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›RECRUITINGphase readoutNCT06705751: Speed-up the Diagnosis and Evaluation of anoMalous Coronary ARTery From the Aorta

Sponsor: IRCCS Policlinico S. Donato. Phase: NA. Conditions: AAOCA, ACAOS, Anomalous Aortic Origin of the Coronary Artery (AAOCA), Anomalous Coronary Artery Arising From the Opposite Sinus, Anomalous Coronary Artery Origin, Anomalous Coronary Artery With Aortic Origin and Course Between the Great Arteries, Coronary Anomaly, Sudden Cardiac Death, Myocardial Ischemia, Myocardial Ischemia, Angina Pectoris

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02296229: Stereotactic Body Radiation Therapy in Treating Patients With Localized High-Risk Prostate Cancer

Sponsor: Jonsson Comprehensive Cancer Center. Phase: NA. Conditions: Adenocarcinoma of the Prostate, Stage III Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07525453: Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults

Sponsor: Fenerbahce University. Phase: NA. Conditions: Balance Disorders, Aging, Risk of Falling in the Elderly

full page →ctgov ↗
›COMPLETEDphase readoutNCT07196137: Comparing the Effect of LTS and Air-Q sp3G LMA Use on Gastric Insufflation Using Ultrasound

Sponsor: Ankara City Hospital Bilkent. Phase: . Conditions: Laryngeal Masks Comparison, Elective Surgeries, Gastric Ultrasonography, Gastric Insufflation

full page →ctgov ↗
›COMPLETEDphase readoutNCT05343637: A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension

Sponsor: Respira Therapeutics, Inc.. Phase: PHASE2. Conditions: Pulmonary Arterial Hypertension

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07338045: The Effects of Eight-Week Baduanjin Exercise on Chronic Low Back Pain and Disability Among Office Workers.

Sponsor: Universiti Sains Malaysia. Phase: NA. Conditions: Low Back Pain, Baduanjin

full page →ctgov ↗
›COMPLETEDphase readoutNCT04553939: Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Urothelial Carcinoma, Bladder Cancer

full page →ctgov ↗
← prev
page 80 of 161
next →